Correlation Between Chase Growth and Pharmaceuticals Ultrasector
Can any of the company-specific risk be diversified away by investing in both Chase Growth and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chase Growth and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chase Growth Fund and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Chase Growth and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chase Growth with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chase Growth and Pharmaceuticals Ultrasector.
Diversification Opportunities for Chase Growth and Pharmaceuticals Ultrasector
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Chase and Pharmaceuticals is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Chase Growth Fund and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Chase Growth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chase Growth Fund are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Chase Growth i.e., Chase Growth and Pharmaceuticals Ultrasector go up and down completely randomly.
Pair Corralation between Chase Growth and Pharmaceuticals Ultrasector
Assuming the 90 days horizon Chase Growth is expected to generate 8.03 times less return on investment than Pharmaceuticals Ultrasector. But when comparing it to its historical volatility, Chase Growth Fund is 2.04 times less risky than Pharmaceuticals Ultrasector. It trades about 0.08 of its potential returns per unit of risk. Pharmaceuticals Ultrasector Profund is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 2,418 in Pharmaceuticals Ultrasector Profund on May 25, 2025 and sell it today you would earn a total of 329.00 from holding Pharmaceuticals Ultrasector Profund or generate 13.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Chase Growth Fund vs. Pharmaceuticals Ultrasector Pr
Performance |
| Timeline |
| Chase Growth |
| Pharmaceuticals Ultrasector |
Chase Growth and Pharmaceuticals Ultrasector Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chase Growth and Pharmaceuticals Ultrasector
The main advantage of trading using opposite Chase Growth and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chase Growth position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.| Chase Growth vs. Cambiar Opportunity Fund | Chase Growth vs. The Chesapeake Growth | Chase Growth vs. The Jensen Portfolio | Chase Growth vs. Aston Montag Caldwell |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |